Evidence map›Paper›PMID 34805253›Full record

ReviewFrontiers in nutrition2021

The Antiviral Activity of Bacterial, Fungal, and Algal Polysaccharides as Bioactive Ingredients: Potential Uses for Enhancing Immune Systems and Preventing Viruses.

Worraprat Chaisuwan, Yuthana Phimolsiripol, Thanongsak Chaiyaso, Charin Techapun, Noppol Leksawasdi, Kittisak Jantanasakulwong, Pornchai Rachtanapun, Sutee Wangtueai, Sarana Rose Sommano, SangGuan You and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 75 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Review
  4. Integrative medicine research · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Inhibition of SARS-CoV-2 infection byMicrobiology spectrum · 2024
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 4 countries.

Worraprat ChaisuwanInterdisciplinary Program in Biotechnology, Graduate School, Chiang Mai University, Chiang Mai, Thailand.
Yuthana PhimolsiripolFaculty of Agro-Industry, Chiang Mai University, Chiang Mai, Thailand.
Thanongsak ChaiyasoFaculty of Agro-Industry, Chiang Mai University, Chiang Mai, Thailand.
Charin TechapunFaculty of Agro-Industry, Chiang Mai University, Chiang Mai, Thailand.
Noppol LeksawasdiFaculty of Agro-Industry, Chiang Mai University, Chiang Mai, Thailand.
Kittisak JantanasakulwongFaculty of Agro-Industry, Chiang Mai University, Chiang Mai, Thailand.
Pornchai RachtanapunFaculty of Agro-Industry, Chiang Mai University, Chiang Mai, Thailand.
Sutee WangtueaiCluster of Agro Bio-Circular-Green Industry (Agro-BCG), Chiang Mai University, Chiang Mai, Thailand.
Sarana Rose SommanoCluster of Agro Bio-Circular-Green Industry (Agro-BCG), Chiang Mai University, Chiang Mai, Thailand.
SangGuan YouDepartment of Marine Food Science and Technology, Gangneung-Wonju National University, Gangneung, South Korea.
Joe M RegensteinDepartment of Food Science, College of Agriculture and Life Science, Cornell University, Ithaca, NY, United States.
Francisco J BarbaDepartment of Preventive Medicine and Public Health, Food Science, Toxicology and Forensic Medicine, Faculty of Pharmacy, Universitat de València, Valencia, Spain.
Phisit SeesuriyachanFaculty of Agro-Industry, Chiang Mai University, Chiang Mai, Thailand.
Chiang Mai University · THCornell University · USGangneung–Wonju National University · KRUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viral infections may cause serious human diseases. For instance, the recent appearance of the novel virus, SARS-CoV-2, causing COVID-19, has spread globally and is a serious public health concern. The consumption of healthy, proper, functional, and nutrient-rich foods has an important role in enhancing an individual's immune system and preventing viral infections. Several polysaccharides from natural sources such as algae, bacteria, and fungi have been considered as generally recognized as safe (GRAS) by the US Food and Drug Administration. They are safe, low-toxicity, biodegradable, and have biological activities. In this review, the bioactive polysaccharides derived from various microorganisms, including bacteria, fungi, and algae were evaluated. Antiviral mechanisms of these polysaccharides were discussed. Finally, the potential use of microbial and algal polysaccharides as an antiviral and immune boosting strategy was addressed. The microbial polysaccharides exhibited several bioactivities, including antioxidant, anti-inflammatory, antimicrobial, antitumor, and immunomodulatory activities. Some microbes are able to produce sulfated polysaccharides, which are well-known to exert a board spectrum of biological activities, especially antiviral properties. Microbial polysaccharide can inhibit various viruses using different mechanisms. Furthermore, these microbial polysaccharides are also able to modulate immune responses to prevent and/or inhibit virus infections. There are many molecular factors influencing their bioactivities, e.g., functional groups, conformations, compositions, and molecular weight. At this stage of development, microbial polysaccharides will be used as adjuvants, nutrient supplements, and for drug delivery to prevent several virus infections, especially SARS-CoV-2 infection.

Indexed as

antiviral activityCOVID-19immunomodulationSARS-CoV-2sulfated polysaccharides

Identifiers

PMID34805253
PMCPMC8602887
OpenAlexW3213306806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.